Dr. Han N. Lee, MD

Dr. Lee practices at Huntington Ambulatory Surgery Center - HOPD in Pasadena, California.

Dr. Lee's NPI, 1558457143, was assigned on October 4, 2006. Dr. Lee graduated from UC Irvine School of Medicine in 1997. Dr. Lee holds California license A80177.

Dr. Lee's primary practice is Huntington Ambulatory Surgery Center - HOPD, at 625 S Fair Oaks Ave, Pasadena, CA 91105.

Dr. Lee's primary practice is Huntington Ambulatory Surgery Center - HOPD in Pasadena, California. The medical group on file is Comprehensive Dermatology Center of Pasadena. Dmand AI also links Dr. Lee to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Lee is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Lee's licenses on file in 2 states: California and Oregon.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, itchy rashes and minor head injury among the conditions Dr. Lee treats.

CMS data shows 8,369 Medicare services from Dr. Lee across 31 procedure codes in 2024, for 590 Medicare patients. Medicare paid $586,552 for them. Every service was in an office.

CMS counts 590 Medicare patients who saw Dr. Lee in 2024. The largest group is 75 to 84, with 256 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 55, with 58% women.

In 2024, Dr. Lee wrote 563 Medicare Part D claims for 315 patients. 98% of them were for generic drugs. CMS names the drug for 468 of them, across 9 drugs with 11 or more claims each, at $6,707 in total drug cost. In 2023, CMS named 557 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Lee for performance year 2024, reported individually. Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 206 procedures of melanoma (skin cancer) excision by Dr. Lee, more than 97% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 18 papers to Dr. Lee, published from 2007 to 2011. 2010 was the busiest year, with 3. The most frequent topics are Immunohistochemistry, Fluorescent Dyes and Hydrogen-Ion Concentration. Dr. Lee has published most often in Int Urogynecol J. Dr. Lee's most frequent co-authors are Shailender Bhatia, MD, Matthew Blackburn, MD and Kathryn B. Bollin, MD.

CMS Open Payments shows 695 general payments to Dr. Lee from 45 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 89% of the total. Allergan Inc. paid the most, $4,749.

Dmand AI lists 6 awards for Dr. Lee, most recently CMS Stage 1 EHR in 2014.

Dr. Lee graduated from UC Irvine School of Medicine in 1997. Dr. Lee is a member of AAD and ASDS.

Dr. Lee is in network with 15 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.